Study of an RSV-hMPV-PIV3 Trivalent Vaccine Candidate VXB-251 in Older Adults

Conditions

• Lower Respiratory Tract Disease
• Healthy Participants

Interventions

• BIOLOGICAL: trivalent (RSV/hMPV/PIV3) vaccine candidate
• BIOLOGICAL: trivalent (RSV/hMPV/PIV3) vaccine candidate
• BIOLOGICAL: trivalent (RSV/hMPV/PIV3) vaccine candidate
• BIOLOGICAL: bivalent (RSV/hMPV) unlicensed comparator
• BIOLOGICAL: monovalent (RSV) unlicensed comparator
• BIOLOGICAL: Biological/Vaccine: monovalent (hMPV) unlicensed comparator
• BIOLOGICAL: monovalent (PIV3) unlicensed comparator
• OTHER: Placebo

Sponsor

Vicebio Australia Proprietary Limited